1 | ACT-385781A (Actelion Epoprostenol) | [1] Epoprostenol Epoprostenol | [1] D00106
D00106
(Name: Epoprostenol) | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
2 | Combination injection of EPO and G-CSF | [1] Filgrastim Filgrastim | [1] D03235
D03235
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1] 6 6 |
3 | Current marketed FLOLAN (epoprostenol sodium) | [1] Epoprostenol Epoprostenol | [1] D00106
D00106
(Name: Epoprostenol) | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
4 | EPO | - | - | - | - | [1] 13 13 |
5 | Epoeitin beta | - | - | - | - | [1] 18 18 |
6 | Epoetin alfa | [1] Erythropoietin Erythropoietin (Synonym: Epoetinum zeta) | - | - | - | [3] 13 13, 18, 46 |
7 | Epoetin beta | [1] Erythropoietin Erythropoietin (Synonym: Epoetinum zeta) | - | - | - | [1] 13 13 |
8 | EPOPROSTENOL | [1] Epoprostenol Epoprostenol | [1] D00106
D00106
(Name: Epoprostenol) | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
9 | Epoprostenol for injection | [1] Epoprostenol Epoprostenol | [1] D00106
D00106
(Name: Epoprostenol) | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
10 | EPOPROSTENOL SODICO | [1] Epoprostenol Epoprostenol | [1] D00106
D00106
(Name: Epoprostenol) | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
11 | EPOPROSTENOL SODIUM | [1] Epoprostenol Epoprostenol | [1] D00106
D00106
(Name: Epoprostenol) | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
12 | Epoprostenol-Actelion | [1] Epoprostenol Epoprostenol | [1] D00106
D00106
(Name: Epoprostenol) | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
13 | Epoprostenolo per iniezione | - | - | - | - | [1] 86 86 |
14 | Erythropoetin (EPO) | - | - | - | - | [1] 2 2 |
15 | Erythropoietin human recombinant (EPOrh) | [1] Erythropoietin Erythropoietin (Synonym: Epoetinum zeta) | - | - | - | [1] 6 6 |
16 | New thermo stable formulation of epoprostenol sodium | [1] Epoprostenol Epoprostenol | [1] D00106
D00106
(Name: Epoprostenol) | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |